MEDILEEN
ActiveSummary
MEDILEEN has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €201k and a net result of €102k. Equity is growing by ~97% per year across the filed fiscal years. Its solvency ranks better than 95% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
95
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days only on tighter terms
Liquidity ample (current ratio 48.19 against 9.82 in 2024; short-term debt: 2% and cash: 33.9% of total assets), and 2.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
97.4%
Return on assets
49.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
79 d early
2024
77 d early
2023
8 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€201k▲ 103%
2024 · €99k
2023: €9k
2024: €99k
2023 → 2025
Total assets
€206k▲ 88.6%
2024 · €109k
2023: €14k
2024: €109k
2023 → 2025
Net result
€102k▲ 13.0%
2024 · €90k
2023: €5k
2024: €90k
2023 → 2025
Working capital
€193k▲ 108%
2024 · €93k
2023: €9k
2024: €93k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€9k-€99k▲ 964%€201k▲ 103%
Operating result€7k-€115k▲ 1,632%€131k▲ 14.0%
Net result€5k-€90k▲ 1,611%€102k▲ 13.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 14% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €206k
Fixed assets
€9k ▲ 51.0%
Current assets
€197k ▲ 90.8%
Equity and liabilities €206k
Equity
€201k ▲ 103%
Debt
€5k ▼ 50.1%
Debt's share of the balance-sheet total falls from 9.7% to 2.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€134k▲
2024 · €117k
Cash flow
€106k▲
2024 · €93k
Current ratio
48.19▲
2024 · 9.82
Debt to equity
0.03▼
2024 · 0.11
ROE
50.8%▼
2024 · 91.5%
ROA
49.5%▼
2024 · 82.6%
Interest coverage
533.17▲
2024 · 487.17
Debt ≤ 1 year
€4k▼
2024 · €10k
Income taxes
€28k▲
2024 · €24k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet
Code20242025
Assets
Total assets20/58€109k€206k▲
Fixed assets21/28€6k€9k▲
Tangible fixed assets22/27€6k€9k▲
Furniture and vehicles24€6k€9k▲
Current assets29/58€103k€197k▲
Amounts receivable within one year40/41€34€15▼
Trade receivables40€34€15▼
Current investments50/53-€100k
Cash at bank and in hand54/58€86k€70k▼
Deferred charges and accrued income490/1€17k€27k▲
Equity and liabilities
Total equity and liabilities10/49€109k€206k▲
Equity10/15€99k€201k▲
Contributions10/11€4k€4k=
Reserves13€95k€95k=
Distributable reserves133€95k€95k=
Profit (loss) carried forward14-€102k
Amounts payable17/49€11k€5k▼
Amounts payable within one year42/48€10k€4k▼
Trade debts44€649€776▲
Suppliers440/4€649€776▲
Taxes, remuneration and social security45€9k€3k▼
Taxes450/3€9k€3k▼
Other amounts payable47/48€859-
Accrued charges and deferred income492/3€62€1k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k▲
Other operating charges640/8€354€868▲
Gross operating margin9900€117k€135k▲
Operating profit (loss)9901€115k€131k▲
Financial income75/76B-€69
Recurring financial income75-€69
Financial charges65/66B€240€251▲
Recurring financial charges65€240€251▲
Profit (loss) for the period before taxes9903€114k€130k▲
Income taxes67/77€24k€28k▲
Profit (loss) for the period9904€90k€102k▲
Profit (loss) for the period to be appropriated9905€90k€102k▲
Appropriation of the result
Profit (loss) to be appropriated9906€96k€102k▲
Profit (loss) brought forward from the previous period14P€5k-
Transfer to equity691/2€95k-
To other reserves6921€95k-
Profit to be distributed694/7€859-
Return on contributions (dividend)694€859-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €102k ▲13%
Operating result €131k, net result €102k, both a record.
31-12
Financial
Liquidity times 5current ratio 48.19
Current ratio from 9.82 to 48.19; short-term debt falls from €10k to €4k.
31-12
Financial
Equity above €200kEq €201k ▲103%
3 profitable years in a row build equity to €201k.
15-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 9.82
Current ratio from 2.97 to 9.82.
23-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 2 establishment units since 2023
Ground area
712 m²
Building footprint
335 m²
Volume, LiDAR
2,014 m³
2 parcels, Flanders · tallest building 13.6 m, ±2 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
2 establishment units
MEDILEEN
since 20232.351.127.570
Gillis Verdonckstraat 1, 2610 Antwerpen
since 20252.375.283.540
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11810K1955/00X011 | Flanders | 367 m² | 1 · 241 m² | 13.6 m · 2 fl. |
| 11462A0022/00D009 | Flanders | 345 m² | 1 · 94 m² | 8.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Stefaan Favoreel
BE 0629.988.868
Kortemark · Eq €200,970
Dr. Johan AP Verhelst
BE 1009.795.932
Boechout · Eq €201,177
DR. DE VOS TANIA
BE 0843.897.723
Schilde · Eq €201,223
Dokter Goossens Kristof
BE 0627.953.353
Beerse · Eq €201,309
DR. KAREL VAN HOOLAND, HUISARTS
BE 0761.383.286
Maarkedal · Eq €201,340
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,406 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-10-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
82100Office administrative and support services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.